{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:43:44Z","timestamp":1740163424224,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Timely knowing glucose level helps diabetic patients to manage the disease, including decisions about food, physical activity and medication. This study compared two continuous glucose monitoring systems in conscious and moving-free nonhuman primates (NHPs,<jats:italic>Macaca fascicularis<\/jats:italic>). Each normoglycemic or diabetic monkey was implanted with one Dexcom G4 Platinum subcutaneously or one HD-XG glucose sensor arterially for glucose monitoring. The glucose levels measured by both telemetry devices significantly correlated with the glucometer readings. The data of oral glucose tolerance test (oGTT) showed that the glucose levels measured by either Dexcom G4 Platinum or HD-XG transmitter were very similar to glucometer readings. However, compared to HD-XG transmitter or glucometer, Dexcom G4 Platinum detected a decreased glucose peak of ivGTT with approximately 10\u2009min delay due to interstitial glucose far behind blood glucose change. Our data showed the advantages of the telemetry systems are: (1) consecutive data collection (day and night); (2) no bleeding; (3) no anesthesia (moving freely); (4) recording natural response without physical restriction and stress; (5) less labor intensity during ivGTT and other tests; (6) quick outcomes without lab tests. This article summarized and compared the differences of the general characteristics of two continuous glucose monitoring systems in diabetic research.<\/jats:p>","DOI":"10.1038\/s41598-017-09806-w","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:21:04Z","timestamp":1503390064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates (Macaca Fascicularis)"],"prefix":"10.1038","volume":"7","author":[{"given":"Bingdi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-429X","authenticated-orcid":false,"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"9806_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.aaf4006","volume":"354","author":"M Xie","year":"2016","unstructured":"Xie, M. et al. \u03b2-cell\u2013mimetic designer cells provide closed-loop glycemic control. Science 354, 1296\u20131301 (2016).","journal-title":"Science"},{"key":"9806_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","volume":"25","author":"A Falkevall","year":"2017","unstructured":"Falkevall, A. et al. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease. Cell Metabolism 25, 713\u2013726 (2017).","journal-title":"Cell Metabolism"},{"key":"9806_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King, A. J. The use of animal models in diabetes research. Br J Pharmacol 166, 877\u201394 (2012).","journal-title":"Br J Pharmacol"},{"key":"9806_CR4","volume":"2013","author":"T Sasase","year":"2013","unstructured":"Sasase, T., Pezzolesi, M. G., Yokoi, N., Yamada, T. & Matsumoto, K. Animal models of diabetes and metabolic disease. J Diabetes Res 2013, 281928 (2013).","journal-title":"J Diabetes Res"},{"key":"9806_CR5","first-page":"245","volume":"23","author":"A Chatzigeorgiou","year":"2009","unstructured":"Chatzigeorgiou, A., Halapas, A., Kalafatakis, K. & Kamper, E. The use of animal models in the study of diabetes mellitus. In Vivo 23, 245\u201358 (2009).","journal-title":"In Vivo"},{"key":"9806_CR6","volume":"2013","author":"MS Islam","year":"2013","unstructured":"Islam, M. S. Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res 2013, 149452 (2013).","journal-title":"J Diabetes Res"},{"key":"9806_CR7","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.S13-010","volume":"S13","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part I. Model of Naturally Occurring Diabetes. J Diabetes Metab S13, 010, doi:10.4172\/2155-6156.S13-010 (2015).","journal-title":"J Diabetes Metab"},{"key":"9806_CR8","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000641","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang, B. et al. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part II. Model of Naturally Occurring or Experimental Obesity. J Diabetes Metab 6, 641, doi:10.4172\/2155-6156.1000641 (2016).","journal-title":"J Diabetes Metab"},{"key":"9806_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/019262301301418955","volume":"29","author":"JD Wagner","year":"2001","unstructured":"Wagner, J. D. et al. Naturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology. Toxicol Pathol 29, 142\u20138 (2001).","journal-title":"Toxicol Pathol"},{"key":"9806_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/193229681200600304","volume":"6","author":"HJ Harwood Jr.","year":"2012","unstructured":"Harwood, H. J. Jr., Listrani, P. & Wagner, J. D. Nonhuman primates and other animal models in diabetes research. J Diabetes Sci Technol 6, 503\u201314 (2012).","journal-title":"J Diabetes Sci Technol"},{"key":"9806_CR11","first-page":"259","volume":"47","author":"JD Wagner","year":"2006","unstructured":"Wagner, J. D. et al. Old World Nonhuman Primate Models of Type 2 Diabetes Mellitus. Oxford Journals Science & Mathematics ILAR Journal 47, 259\u2013271 (2006).","journal-title":"Oxford Journals Science & Mathematics ILAR Journal"},{"key":"9806_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/785948","volume":"2014","author":"H Zhu","year":"2014","unstructured":"Zhu, H., Yu, L., He, Y. & Wang, B. Nonhuman primate models of type 1 diabetes mellitus for islet transplantation. J Diabetes Res 2014, 785948 (2014).","journal-title":"J Diabetes Res"},{"key":"9806_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/diagnostics3040385","volume":"3","author":"SK Vashist","year":"2013","unstructured":"Vashist, S. K. Continuous Glucose Monitoring Systems: A Review. Diagnostics (Basel) 3, 385\u2013412 (2013).","journal-title":"Diagnostics (Basel)"},{"key":"9806_CR14","doi-asserted-by":"publisher","unstructured":"Facchinetti, A., Del Favero S, Sparacino G, Cobelli C. Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices. Medical & biological engineering & computing, doi:10.1007\/s11517-014-1226-ypmid:25416850 (2014).","DOI":"10.1007\/s11517-014-1226-ypmid:25416850"},{"key":"9806_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09674845.2012.12002443","volume":"69","author":"SF Clarke","year":"2012","unstructured":"Clarke, S. F. & Foster, J. R. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci 69, 83\u201393 (2012).","journal-title":"Br J Biomed Sci"},{"key":"9806_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/1932296815586424","volume":"9","author":"R Brockway","year":"2015","unstructured":"Brockway, R. et al. Fully Implantable Arterial Blood Glucose Device for Metabolic Research Applications in Rats for Two Months. J Diabetes Sci Technol 9, 771\u201381 (2015).","journal-title":"J Diabetes Sci Technol"},{"key":"9806_CR17","doi-asserted-by":"publisher","unstructured":"Wang, B. et al. Long-term Blood Glucose Monitoring with Implanted Telemetry Device in Conscious and Stress-free Cynomolgus Monkeys. J Endocrinol Invest, doi:10.1007\/s40618-017-0651-9 (2017).","DOI":"10.1007\/s40618-017-0651-9"},{"key":"9806_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-62703-068-7_11","volume":"933","author":"BC Hansen","year":"2012","unstructured":"Hansen, B. C. Investigation and treatment of type 2 diabetes in nonhuman primates. Methods Mol Biol 933, 177\u201385 (2012).","journal-title":"Methods Mol Biol"},{"key":"9806_CR19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.5.847a","volume":"16","author":"BC Hansen","year":"1993","unstructured":"Hansen, B. C. & Bodkin, N. L. Standardization of IVGTT. Importance of method used to calculate glucose disappearance. Diabetes Care 16, 847 (1993).","journal-title":"Diabetes Care"},{"key":"9806_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2253-13-33","volume":"13","author":"YF Xiao","year":"2013","unstructured":"Xiao, Y. F. et al. Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys. BMC Anesthesiol 13, 33 (2013).","journal-title":"BMC Anesthesiol"},{"key":"9806_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-5-40","volume":"5","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Quantification of beta-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeys. Diabetol Metab Syndr 5, 40 (2013).","journal-title":"Diabetol Metab Syndr"},{"key":"9806_CR22","unstructured":"Wang, B. et al. Advantages of Glucose Monitoring with Implantable Telemetry in Freely Moving Conscious Nonhuman Primates. ADA annual conference (2016)."},{"key":"9806_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2016.19976","volume":"317","author":"M Lind","year":"2017","unstructured":"Lind, M., Polonsky, M. & Hirsch, I. B. et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA 317, 379\u2013387 (2017).","journal-title":"JAMA"},{"key":"9806_CR24","doi-asserted-by":"publisher","unstructured":"Garg, S. K. & Akturk, H. K. Flash Glucose Monitoring: The Future Is Here. Diabetes Technol Ther 19, doi:10.1089\/dia.2017.0037 (2017).","DOI":"10.1089\/dia.2017.0037"},{"key":"9806_CR25","doi-asserted-by":"publisher","first-page":"S2-3","DOI":"10.1089\/dia.2015.0417","volume":"18","author":"D Rodbard","year":"2016","unstructured":"Rodbard, D. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther 18, S2-3\u2013S2-13 (2016).","journal-title":"Diabetes Technol Ther"},{"key":"9806_CR26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.2337\/db13-1649","volume":"63","author":"DR Burnett","year":"2014","unstructured":"Burnett, D. R., Huyett, L. M., Zisser, H. C., Doyle, F. J. 3rd & Mensh, B. D. Glucose sensing in the peritoneal space offers faster kinetics than sensing in the subcutaneous space. Diabetes 63, 2498\u2013505 (2014).","journal-title":"Diabetes"},{"key":"9806_CR27","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.2337\/db13-1132","volume":"62","author":"A Basu","year":"2013","unstructured":"Basu, A. et al. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes 62, 4083\u20137 (2013).","journal-title":"Diabetes"},{"key":"9806_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1017\/S0007114509991504","volume":"103","author":"L Dye","year":"2010","unstructured":"Dye, L. et al. Correspondence of continuous interstitial glucose measurement against arterialised and capillary glucose following an oral glucose tolerance test in healthy volunteers. Br J Nutr 103, 134\u201340 (2010).","journal-title":"Br J Nutr"},{"key":"9806_CR29","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.2337\/diabetes.52.11.2790","volume":"52","author":"MS Boyne","year":"2003","unstructured":"Boyne, M. S., Silver, D. M., Kaplan, J. & Saudek, C. D. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 52, 2790\u20134 (2003).","journal-title":"Diabetes"},{"key":"9806_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0927-7765(99)00148-4","volume":"18","author":"N Wisniewski","year":"2000","unstructured":"Wisniewski, N. & Reichert, M. Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces 18, 197\u2013219 (2000).","journal-title":"Colloids Surf B Biointerfaces"},{"key":"9806_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/dia.2004.6.635","volume":"6","author":"PJ Stout","year":"2004","unstructured":"Stout, P. J., Racchini, J. R. & Hilgers, M. E. A novel approach to mitigating the physiological lag between blood and interstitial fluid glucose measurements. Diabetes Technol Ther 6, 635\u201344 (2004).","journal-title":"Diabetes Technol Ther"},{"key":"9806_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/193229681100500318","volume":"5","author":"KL Helton","year":"2011","unstructured":"Helton, K. L., Ratner, B. D. & Wisniewski, N. A. Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and foreign body response-part II: examples and application. J Diabetes Sci Technol 5, 647\u201356 (2011).","journal-title":"J Diabetes Sci Technol"},{"key":"9806_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/193229681300700408","volume":"7","author":"BD Mensh","year":"2013","unstructured":"Mensh, B. D., Wisniewski, N. A., Neil, B. M. & Burnett, D. R. Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol 7, 863\u201370 (2013).","journal-title":"J Diabetes Sci Technol"},{"key":"9806_CR34","doi-asserted-by":"crossref","unstructured":"Gough, D. A., Kumosa, L. S., Routh, T. L., Lin, J. T. & Lucisano, J. Y. Function of an implanted tissue glucose sensor for more than 1 year in animals. Sci Transl Med 2, 42ra53 (2010).","DOI":"10.1126\/scitranslmed.3001148"},{"key":"9806_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2527\/1997.751249x","volume":"75","author":"T Grandin","year":"1997","unstructured":"Grandin, T. Assessment of stress during handling and transport. J Anim Sci 75, 249\u2013257 (1997).","journal-title":"J Anim Sci"},{"key":"9806_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1034\/j.1600-0684.2003.00018.x","volume":"32","author":"KL Bentson","year":"2003","unstructured":"Bentson, K. L., Capitanio, J. P. & Mendoza, S. P. Cortisol responses to immobilization with Telazol or ketamine in baboons (Papio cynocephalus\/anubis) and rhesus macaques (Macaca mulatta). J Med Primatol 32, 148\u2013160 (2003).","journal-title":"J Med Primatol"},{"key":"9806_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-13-46","volume":"13","author":"LN Vandenberg","year":"2014","unstructured":"Vandenberg, L. N., Welshons, W. V., Saal, F. S. V., Toutain, P.-L. & Myers, J. P. Should oral gavage be abandoned in toxicity testing of endocrine disruptors? Environmental Health 13, 46 (2014).","journal-title":"Environmental Health"},{"key":"9806_CR38","first-page":"842","volume":"51","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Drug-Containing Gelatin Treats as an Alternative to Gavage for Long-Term Oral Administration in Rhesus Monkeys (Macaca mulatta). J Am Assoc Lab Anim Sci 51, 842\u2013846 (2012).","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"9806_CR39","first-page":"42","volume":"43","author":"JP Balcombe","year":"2004","unstructured":"Balcombe, J. P., Barnard, N. D. & Sandusky, C. Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43, 42\u201351 (2004).","journal-title":"Contemp Top Lab Anim Sci"},{"key":"9806_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.physbeh.2010.04.001","volume":"100","author":"VE De Meijer","year":"2010","unstructured":"De Meijer, V. E., Le, H. D., Meisel, J. A. & Puder, M. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav 100, 387\u2013393 (2010).","journal-title":"Physiol Behav"},{"key":"9806_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.taap.2012.01.025","volume":"260","author":"MK Walkera","year":"2012","unstructured":"Walkera, M. K. et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol 260, 65\u201369 (2012).","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09806-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:25:46Z","timestamp":1692941146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09806-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09806-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2017,8,29]]},"assertion":[{"value":"30 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the authors are employee of Crown Bioscience Inc. The authors declare no conflict of interest in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9596"}}